Sign inJoin waitlistJoin the waitlist

Michael Grunwald

Co-Leader · Carolinas Medical Center

Credentials: · · · · · · ·

History

Carolinas Medical Center
Present
Wake Forest University Baptist Medical Center
Present

Hematology and Medical Oncology
Johns Hopkins University School of Medicine
2009–2012
Internal Medicine
Johns Hopkins University School of Medicine
2006–2009
Johns Hopkins Univ Sch of Med
2002–2006

Research

Phase 2 study of azacytidine plus sorafenib in patients with acute myeloid leukemia and FLT-3 internal tandem duplication mutation
Blood · 2013 · 326 citations
Effect of the 2011 vs 2003 duty hour regulation-compliant models on sleep duration, trainee education, and continuity of patient care among internal medicine house staff: a…
JAMA Internal Medicine · 2013 · 217 citations
HLA-haploidentical vs matched unrelated donor transplants with posttransplant cyclophosphamide-based prophylaxis
Blood · 2021 · 151 citations

Edward Copelan
33 papers
TN
Taiga Nishihori
31 papers
Wael Saber
31 papers
Mohamed Dabaja
24 papers
Mark Litzow
23 papers
MS
Melhem Solh
23 papers
BS
Bipin Savani
22 papers
David Rizzieri
21 papers
Hillard Lazarus
21 papers
BW
Baldeep Wirk
20 papers
Siddhartha Ganguly
20 papers
Amer Beitinjaneh
19 papers

Clinical trials

Leukemia Stem Cell Detection in Acute Myeloid Leukemia
Principal investigator · Terminated · Phase 3
Wake Forest University Health Sciences
2016–2018
Venetoclax and HMA Treatment of Older and Unfit Adults With FLT3 Mutated Acute Myeloid Leukemia (AML) (A MyeloMATCH Treatment Trial)
Site PI · Recruiting · Phase 2
National Cancer Institute (NCI)
2024–2029